Pharmaceutical Technology47m
Keymed’s Stapokibart approved by NMPA for seasonal allergic rhinitis
China's NMPA has granted approval for Keymed Biosciences’ supplemental NDA of Stapokibart to treat seasonal allergic rhinitis ...
cnbctv182h
Lupin secures US FDA approval for generic version of Atrovent nasal spray
Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
'I'm a dentist - sleep trend could be dangerous for people with conditions'
She said: "If your nose is even slightly blocked and you tape your mouth shut, you may struggle to get enough oxygen, leading ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...